{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:57:14Z","timestamp":1780995434051,"version":"3.54.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejphar.2021.174568","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T16:29:08Z","timestamp":1634315348000},"page":"174568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Gene-editing, immunological and iPSCs based therapeutics for muscular dystrophy"],"prefix":"10.1016","volume":"912","author":[{"given":"Shagun","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya","family":"Kunja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep S.","family":"Dhoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5263-7511","authenticated-orcid":false,"given":"Narender K.","family":"Dhania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5966\/sctm.2013-0095","article-title":"Myogenic differentiation of muscular dystrophy\u2010specific induced pluripotent stem cells for use in drug discovery","volume":"3","author":"Abujarour","year":"2014","journal-title":"Stem cells translational medicine"},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.biocel.2010.11.005","article-title":"Duchenne muscular dystrophy--what causes the increased membrane permeability in skeletal muscle?","volume":"43","author":"Allen","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2021.174568_bib4","series-title":"Superoxide-forming Enzyme from Human Neutrophils: Evidence for a Flavin Requirement","author":"Babior","year":"1977"},{"issue":"7","key":"10.1016\/j.ejphar.2021.174568_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.nmd.2017.04.006","article-title":"Late-onset limb-girdle muscular dystrophy caused by GMPPB mutations","volume":"27","author":"Balcin","year":"2017","journal-title":"Neuromuscul. Disord."},{"issue":"34","key":"10.1016\/j.ejphar.2021.174568_bib6","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1073\/pnas.1103509108","article-title":"Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors","volume":"108","author":"Ban","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/19768354.2018.1451367","article-title":"Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts","volume":"22","author":"Bang","year":"2018","journal-title":"Anim. Cell Syst."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib8","first-page":"709","article-title":"Selected small molecules as inducers of pluripotency","volume":"63","author":"Baranek","year":"2016","journal-title":"Acta Biochim. Pol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0976-3147.112777","article-title":"Deletion pattern in the dystrophin gene in Duchenne muscular dystrophy patients in northeast India","volume":"4","author":"Basumatary","year":"2013","journal-title":"J. Neurosci. Rural Pract."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1083\/jcb.144.6.1113","article-title":"Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source","volume":"144","author":"Beauchamp","year":"1999","journal-title":"The Journal of cell biology"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI118101","article-title":"Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine","volume":"96","author":"Bernasconi","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/17460751.2.3.275","article-title":"Multipotential mesoangioblast stem cell therapy in the mdx\/utrn-\/- mouse model for Duchenne muscular dystrophy","volume":"2","author":"Berry","year":"2007","journal-title":"Regen. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1163\/156856207779116711","article-title":"The behavior of neural stem cells on biodegradable synthetic polymers","volume":"18","author":"Bhang","year":"2007","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ejphar.2021.174568_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.compbiolchem.2016.07.005","article-title":"In-silico structural analysis of E509K mutation in LARGE and T192M mutation in Alpha Dystroglycan in the inhibition of glycosylation of Alpha Dystroglycan by LARGE","volume":"64","author":"Bhattacharya","year":"2016","journal-title":"Comput. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.stem.2007.08.008","article-title":"Generation of induced pluripotent stem cells in the absence of drug selection","volume":"1","author":"Blelloch","year":"2007","journal-title":"Cell stem cell"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/0929867023371229","article-title":"Progress towards the discovery of xanthine oxidase inhibitors","volume":"9","author":"Borges","year":"2002","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.stem.2008.01.004","article-title":"Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells","volume":"2","author":"Brambrink","year":"2008","journal-title":"Cell stem cell"},{"issue":"5","key":"10.1016\/j.ejphar.2021.174568_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.cdd.4401874","article-title":"Targeting NF-\u03baB in hematologic malignancies","volume":"13","author":"Braun","year":"2006","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.ejphar.2021.174568_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/jhg.2011.65","article-title":"Novel and recurrent EMD mutations in patients with Emery-Dreifuss muscular dystrophy, identify exon 2 as a mutation hot spot","volume":"56","author":"Brown","year":"2011","journal-title":"J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.ejphar.2021.174568_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/antiox8120581","article-title":"N-acetylcysteine decreases fibrosis and increases force-generating capacity of mdx diaphragm","volume":"8","author":"Burns","year":"2019","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5966\/sctm.2014-0202","article-title":"Concise review: making and using clinically compliant pluripotent stem cell lines","volume":"4","author":"Carpenter","year":"2015","journal-title":"Stem cells translational medicine"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.05.049","article-title":"Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles","volume":"134","author":"Cerletti","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-079X.2010.00752.x","article-title":"Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative\/oxidative stress in patients suffering from Duchenne muscular dystrophy","volume":"48","author":"Chahbouni","year":"2010","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib25","first-page":"31","article-title":"MicroRNA-induced pluripotent stem cells","volume":"7","author":"Chang","year":"2010","journal-title":"Cell stem cell"},{"issue":"5","key":"10.1016\/j.ejphar.2021.174568_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nmeth.1593","article-title":"Chemically defined conditions for human iPSC derivation and culture","volume":"8","author":"Chen","year":"2011","journal-title":"Nat. Methods"},{"issue":"9","key":"10.1016\/j.ejphar.2021.174568_bib27","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.yexcr.2006.01.024","article-title":"Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting","volume":"312","author":"Chen","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(00)81064-8","article-title":"Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity","volume":"84","author":"Chen","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/jcp.21230","article-title":"Small RNAs: regulators and guardians of the genome","volume":"213","author":"Chu","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.ejphar.2021.174568_bib30","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamaneurol.2020.1264","article-title":"Safety, tolerability, and efficacy of viltolarsen in boys with duchenne muscular dystrophy amenable to exon 53 skipping: a phase 2 randomized clinical trial","volume":"77","author":"Clemens","year":"2020","journal-title":"JAMA neurology"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbamem.2013.08.023","article-title":"Dystrophin complex functions as a scaffold for signalling proteins","volume":"1838","author":"Constantin","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejphar.2021.174568_bib32","first-page":"66","article-title":"Scrofola del sistema muscolare","volume":"2","author":"Conte","year":"1836","journal-title":"Annali Clinici dell\u2019Ospedale degli Incurabili di Napoli"},{"issue":"12","key":"10.1016\/j.ejphar.2021.174568_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.molmed.2007.10.003","article-title":"New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials","volume":"13","author":"Cossu","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174568_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-01430-8","article-title":"Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis","volume":"15","author":"Crisafulli","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01243426","article-title":"The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution","volume":"46","author":"Dalmaz","year":"1979","journal-title":"Journal of neural transmission"},{"issue":"12","key":"10.1016\/j.ejphar.2021.174568_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/cells7120253","article-title":"Induced pluripotent stem cells for Duchenne muscular dystrophy modeling and therapy","volume":"7","author":"Danisovic","year":"2018","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ejphar.2021.174568_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","article-title":"Human ES-and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice","volume":"10","author":"Darabi","year":"2012","journal-title":"Cell stem cell"},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clnu.2012.06.001","article-title":"N-Acetylcysteine treatment reduces TNF-\u03b1 levels and myonecrosis in diaphragm muscle of mdx mice","volume":"32","author":"de Senzi Moraes Pinto","year":"2013","journal-title":"Clinical Nutrition"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JND-140045","article-title":"The epidemiology of neuromuscular disorders: a comprehensive overview of the literature","volume":"2","author":"Deenen","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"issue":"6642","key":"10.1016\/j.ejphar.2021.174568_bib40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/41493","article-title":"A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB","volume":"388","author":"DiDonato","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(98)00258-5","article-title":"Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state","volume":"161","author":"Disatnik","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"7730","key":"10.1016\/j.ejphar.2021.174568_bib42","first-page":"501","article-title":"Intrathecal route of drug delivery can save lives or improve quality of life","volume":"289","author":"Dodou","year":"2012","journal-title":"Pharm. J."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib43","doi-asserted-by":"crossref","first-page":"12575","DOI":"10.1038\/s41598-017-12981-5","article-title":"Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy","volume":"7","author":"Doorenweerd","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ejphar.2021.174568_bib44","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ymthe.2018.08.010","article-title":"CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo","volume":"26","author":"Duch\u00eane","year":"2018","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2014a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul. Disord."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib46","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ejphar.2021.174568_bib47","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1113\/expphysiol.2010.053025","article-title":"Progress in therapy for Duchenne muscular dystrophy","volume":"96","author":"Fairclough","year":"2011","journal-title":"Exp. Physiol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.2213","article-title":"T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid\/mdx mouse","volume":"213","author":"Farini","year":"2007","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib49","article-title":"Deletion of dystrophin in-frame exon 5 leads to a severe phenotype: guidance for exon skipping strategies","volume":"11","author":"Fraidenraich","year":"2016","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.ejphar.2021.174568_bib50","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/elps.200406013","article-title":"Differential expression of the skeletal muscle proteome in mdx mice at different ages","volume":"25","author":"Ge","year":"2004","journal-title":"Electrophoresis"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib51","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tips.2005.02.005","article-title":"Mitochondrial nitric oxide synthase","volume":"26","author":"Ghafourifar","year":"2005","journal-title":"Trends in pharmacological sciences"},{"issue":"11","key":"10.1016\/j.ejphar.2021.174568_bib52","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/mt.2012.188","article-title":"Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation","volume":"20","author":"Goudenege","year":"2012","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.ejphar.2021.174568_bib53","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1212\/WNL.0000000000001303","article-title":"Prevalence of congenital muscular dystrophy in Italy: a population study","volume":"84","author":"Graziano","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1096\/fj.03-1024com","article-title":"Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis","volume":"18","author":"Grounds","year":"2004","journal-title":"Faseb j"},{"key":"10.1016\/j.ejphar.2021.174568_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-020-00288-1","article-title":"Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy","volume":"53","author":"He","year":"2020","journal-title":"Biol. Res."},{"issue":"7","key":"10.1016\/j.ejphar.2021.174568_bib56","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.bbadis.2015.03.012","article-title":"Altered ROS production, NF-\u03baB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cells","volume":"1852","author":"Henr\u00edquez-Olgu\u00edn","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.ejphar.2021.174568_bib57","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.bbadis.2015.03.012","article-title":"Altered ROS production, NF-\u03baB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cells","volume":"1852","author":"Henr\u00edquez-Olgu\u00edn","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"9\u201310","key":"10.1016\/j.ejphar.2021.174568_bib58","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","article-title":"Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice","volume":"16","author":"Hodgetts","year":"2006","journal-title":"Neuromuscul. Disord."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174568_bib59","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5966\/sctm.2013-0143","article-title":"Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere\u2010based culture","volume":"3","author":"Hosoyama","year":"2014","journal-title":"Stem cells translational medicine"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","article-title":"TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways","volume":"84","author":"Hsu","year":"1996","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12929-019-0578-x","article-title":"Human iPSC banking: barriers and opportunities","volume":"26","author":"Huang","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2021.174568_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.29328\/journal.jgmgt.1001003","article-title":"The advances and challenges of gene therapy for Duchenne muscular dystrophy","volume":"1","author":"Iyombe-Engembe","year":"2017","journal-title":"J Genetic Med Gene Therapy"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41587-019-0103-5","article-title":"Duchenne muscular dystrophy awaits gene therapy","volume":"37","author":"Jones","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"7669","key":"10.1016\/j.ejphar.2021.174568_bib64","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ejphar.2021.174568_bib65","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/tx900086v","article-title":"Macrophages and inflammatory mediators in chemical toxicity: a battle of forces","volume":"22","author":"Laskin","year":"2009","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nmd.2016.12.005","article-title":"Prevalence of myotonic dystrophy type 1 in adults in western Sweden","volume":"27","author":"Lindberg","year":"2017","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/neup.12549","article-title":"Identification of a novel SGCA missense mutation in a case of limb-girdle muscular dystrophy 2D with the absence of four sarcoglycan proteins","volume":"39","author":"Lu","year":"2019","journal-title":"Neuropathology : official journal of the Japanese Society of Neuropathology"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"MacMicking","year":"1997","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib69","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","article-title":"Three-dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering","volume":"23","author":"Maffioletti","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/cjn.2015.311","article-title":"A systematic review and meta-analysis on the epidemiology of the muscular dystrophies","volume":"43","author":"Mah","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib71","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.stem.2008.11.008","article-title":"Guidelines and techniques for the generation of induced pluripotent stem cells","volume":"3","author":"Maherali","year":"2008","journal-title":"Cell stem cell"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib72","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ebiom.2015.03.018","article-title":"IL-6 Blockade as a therapeutic approach for duchenne muscular dystrophy","volume":"2","author":"Mammen","year":"2015","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.ejphar.2021.174568_bib73","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ejphar.2021.174568_bib74","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib75","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.pmrj.2009.02.013","article-title":"Mesenchymal stem cells: emerging therapy for duchenne muscular dystrophy","volume":"1","author":"Markert","year":"2009","journal-title":"PM&R"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms10488","article-title":"The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype","volume":"7","author":"Martone","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib77","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.ddstr.2013.11.003","article-title":"Old and new biomarkers of oxidative stress in heart failure","volume":"9","author":"Menazza","year":"2012","journal-title":"Drug Discov. Today Ther. Strat."},{"issue":"15","key":"10.1016\/j.ejphar.2021.174568_bib78","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne's muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5339","key":"10.1016\/j.ejphar.2021.174568_bib79","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.278.5339.860","article-title":"IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation","volume":"278","author":"Mercurio","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib80","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/mus.10319","article-title":"Early prednisone treatment in Duchenne muscular dystrophy","volume":"27","author":"Merlini","year":"2003","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib81","first-page":"16","article-title":"Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age","volume":"30","author":"Messina","year":"2011","journal-title":"Acta Myol."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib83","doi-asserted-by":"crossref","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Science advances"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib84","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/jhg.2008.8","article-title":"Characterization of deletion breakpoints in patients with dystrophinopathy carrying a deletion of exons 45-55 of the Duchenne muscular dystrophy (DMD) gene","volume":"54","author":"Miyazaki","year":"2009","journal-title":"J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib85","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.stem.2011.05.001","article-title":"Reprogramming of mouse and human cells to pluripotency using mature microRNAs","volume":"8","author":"Miyoshi","year":"2011","journal-title":"Cell stem cell"},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib86","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/01616412.2015.1105625","article-title":"A novel mutation in alpha sarcoglycan gene in an Iranian family with limb girdle muscular dystrophy 2D","volume":"38","author":"Mojbafan","year":"2016","journal-title":"Neurol. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib87","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/01.WNL.0000049913.27181.51","article-title":"Activation of nuclear factor-\u03baB in inflammatory myopathies and Duchenne muscular dystrophy","volume":"60","author":"Monici","year":"2003","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ejphar.2021.174568_bib88","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00109-008-0308-4","article-title":"NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases","volume":"86","author":"Mourkioti","year":"2008","journal-title":"Journal of molecular medicine (Berlin, Germany)"},{"key":"10.1016\/j.ejphar.2021.174568_bib89","series-title":"Pericyte Biology in Disease","first-page":"319","article-title":"Pericytes in muscular dystrophies","author":"Moyle","year":"2019"},{"key":"10.1016\/j.ejphar.2021.174568_bib90","series-title":"TRAPPC11-Related Muscular Dystrophy with Hypoglycosylation of Alpha-Dystroglycan in Skeletal Muscle and Brain","author":"Munot","year":"2020"},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib91","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib92","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.freeradbiomed.2005.08.043","article-title":"The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy","volume":"40","author":"Nelson","year":"2006","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib93","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni1328","article-title":"See no evil, hear no evil, do no evil: the lessons of immune privilege","volume":"7","author":"Niederkorn","year":"2006","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.ejphar.2021.174568_bib94","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.nmd.2008.07.009","article-title":"Transcription-terminating mutation in telethonin causing autosomal recessive muscular dystrophy type 2G in a European patient","volume":"18","author":"Oliv\u00e9","year":"2008","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170280","article-title":"Epidemiological and molecular characterization of a Mexican population isolate with high prevalence of limb-girdle muscular dystrophy type 2A due to a novel calpain-3 mutation","volume":"12","author":"Pantoja-Melendez","year":"2017","journal-title":"PLoS One"},{"issue":"6203","key":"10.1016\/j.ejphar.2021.174568_bib96","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/337176a0","article-title":"Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts","volume":"337","author":"Partridge","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174568_bib97","doi-asserted-by":"crossref","first-page":"101714","DOI":"10.1016\/j.scr.2020.101714","article-title":"Generation of two iPSC lines (FAMRCi006-A and FAMRCi006-B) from patient with dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy associated with genetic variant LMNAp.Arg527Pro","volume":"43","author":"Perepelina","year":"2020","journal-title":"Stem Cell Res."},{"issue":"8","key":"10.1016\/j.ejphar.2021.174568_bib98","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"23","key":"10.1016\/j.ejphar.2021.174568_bib99","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1113\/JP274229","article-title":"Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy","volume":"595","author":"Pinniger","year":"2017","journal-title":"The Journal of physiology"},{"issue":"5","key":"10.1016\/j.ejphar.2021.174568_bib100","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4161\/cc.11.5.19300","article-title":"The role of TRADD in death receptor signaling","volume":"11","author":"Pobezinskaya","year":"2012","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.ejphar.2021.174568_bib101","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00415-019-09380-3","article-title":"Mutation pattern in 606 Duchenne muscular dystrophy children with a comparison between familial and non-familial forms: a study in an Indian large single-center cohort","volume":"266","author":"Polavarapu","year":"2019","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib102","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bbadis.2006.08.011","article-title":"Stem cell based therapies to treat muscular dystrophy","volume":"1772","author":"Price","year":"2007","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2021.174568_bib103","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.yjmcc.2012.11.011","article-title":"X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates [Ca2+] i","volume":"58","author":"Prosser","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib104","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jcp.20740","article-title":"Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development","volume":"209","author":"Rafii","year":"2006","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1542\/peds.98.1.103","article-title":"Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury","volume":"98","author":"Saugstad","year":"1996","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2010.06.003","article-title":"Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells","volume":"7","author":"Seki","year":"2010","journal-title":"Cell stem cell"},{"key":"10.1016\/j.ejphar.2021.174568_bib107","series-title":"Stem Cells as a Therapeutic Modality in Muscular Dystrophy","author":"Sharma","year":"2017"},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib108","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3126\/ajms.v8i6.18281","article-title":"Duchenne muscular dystrophy: a immunohistochemical profile and deletion pattern in dystrophin gene in North Indian population","volume":"8","author":"Sharma","year":"2017","journal-title":"Asian J. Med. Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174568_bib109","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.stem.2008.10.004","article-title":"Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds","volume":"3","author":"Shi","year":"2008","journal-title":"Cell stem cell"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1756285615586123","article-title":"Duchenne muscular dystrophy: current cell therapies","volume":"8","author":"Sienkiewicz","year":"2015","journal-title":"Therapeutic advances in neurological disorders"},{"issue":"19","key":"10.1016\/j.ejphar.2021.174568_bib111","doi-asserted-by":"crossref","first-page":"11204","DOI":"10.1074\/jbc.271.19.11204","article-title":"Neuronal nitric-oxide synthase-\u03bc, an alternatively spliced isoform expressed in differentiated skeletal muscle (\u2217)","volume":"271","author":"Silvagno","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejphar.2021.174568_bib112","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/jnen\/62.9.951","article-title":"Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms","volume":"62","author":"Skuk","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib113","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nmd.2006.10.003","article-title":"First test of a \u201chigh-density injection\u201d protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up","volume":"17","author":"Skuk","year":"2007","journal-title":"Neuromuscul. Disord."},{"issue":"9","key":"10.1016\/j.ejphar.2021.174568_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003222","article-title":"Efficacy and safety of vamorolone in Duchenne muscular dystrophy: an 18-month interim analysis of a non-randomized open-label extension study","volume":"17","author":"Smith","year":"2020","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/clim.2000.4966","article-title":"Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle","volume":"98","author":"Spencer","year":"2001","journal-title":"Clin. Immunol."},{"issue":"6\u20137","key":"10.1016\/j.ejphar.2021.174568_bib116","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0960-8966(01)00198-5","article-title":"Do immune cells promote the pathology of dystrophin-deficient myopathies?","volume":"11","author":"Spencer","year":"2001","journal-title":"Neuromuscul. Disord."},{"issue":"5903","key":"10.1016\/j.ejphar.2021.174568_bib117","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1162494","article-title":"Induced pluripotent stem cells generated without viral integration","volume":"322","author":"Stadtfeld","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib118","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1152\/physrev.2001.81.1.209","article-title":"Physiology of nitric oxide in skeletal muscle","volume":"81","author":"Stamler","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2021.174568_bib119","doi-asserted-by":"crossref","first-page":"155134","DOI":"10.1016\/j.cyto.2020.155134","article-title":"Interleukin-6: a neuro-active cytokine contributing to cognitive impairment in Duchenne muscular dystrophy?","volume":"133","author":"Stephenson","year":"2020","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174568_bib120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00019052-199704000-00016","article-title":"Muscular dystrophies and the dystrophin-glycoprotein complex","volume":"10","author":"Straub","year":"1997","journal-title":"Curr. Opin. Neurol."},{"issue":"13","key":"10.1016\/j.ejphar.2021.174568_bib121","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1111\/j.1742-4658.2008.06488.x","article-title":"Structure, regulation and evolution of Nox\u2010family NADPH oxidases that produce reactive oxygen species","volume":"275","author":"Sumimoto","year":"2008","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib122","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"140","key":"10.1016\/j.ejphar.2021.174568_bib123","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2021.174568_bib124","series-title":"Becker Muscular Dystrophy","author":"Thada","year":"2020"},{"issue":"6","key":"10.1016\/j.ejphar.2021.174568_bib125","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s10038-018-0439-6","article-title":"Clinical and molecular consequences of exon 78 deletion in DMD gene","volume":"63","author":"Traverso","year":"2018","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib126","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00441-011-1185-7","article-title":"Regeneration of skeletal muscle","volume":"347","author":"Turner","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174568_bib127","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1021\/acsomega.9b02911","article-title":"Tissue-specificity of dystrophin-actin interactions: isoform-specific thermodynamic stability and actin-binding function of tandem calponin-homology domains","volume":"5","author":"Upadhyay","year":"2020","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.ejphar.2021.174568_bib128","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002928","article-title":"Mending a broken heart: the role of sarcospan in duchenne muscular dystrophy-associated cardiomyopathy","volume":"4","author":"Vander Heide","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib129","first-page":"54","article-title":"Routes of drug administration","volume":"1","author":"Verma","year":"2010","journal-title":"International Journal of Pharmaceutical Studies and Research"},{"issue":"10","key":"10.1016\/j.ejphar.2021.174568_bib130","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.4049\/jimmunol.1101267","article-title":"IFN-\u03b3 promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation","volume":"187","author":"Villalta","year":"2011","journal-title":"The Journal of Immunology"},{"issue":"10","key":"10.1016\/j.ejphar.2021.174568_bib131","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.4049\/jimmunol.1101267","article-title":"IFN-\u03b3 promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation","volume":"187","author":"Villalta","year":"2011","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174568_bib132","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/hmg\/ddn376","article-title":"Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy","volume":"18","author":"Villalta","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174568_bib133","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell stem cell"},{"key":"10.1016\/j.ejphar.2021.174568_bib134","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.omtn.2018.09.017","article-title":"NS-065\/NCNP-01: an antisense oligonucleotide for potential treatment of exon 53 skipping in duchenne muscular dystrophy","volume":"13","author":"Watanabe","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"12","key":"10.1016\/j.ejphar.2021.174568_bib135","doi-asserted-by":"crossref","first-page":"e15354","DOI":"10.1371\/journal.pone.0015354","article-title":"Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse","volume":"5","author":"Whitehead","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174568_bib136","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0378-4274(95)03557-5","article-title":"Nitric oxide (NO) protects against cellular damage by reactive oxygen species","volume":"82","author":"Wink","year":"1995","journal-title":"Toxicology letters"},{"key":"10.1016\/j.ejphar.2021.174568_bib137","series-title":"Human Pluripotent Stem Cells","first-page":"87","article-title":"Transgene-free production of pluripotent stem cells using piggyBac transposons","author":"Woltjen","year":"2011"},{"issue":"11","key":"10.1016\/j.ejphar.2021.174568_bib138","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/nu8110713","article-title":"Nutraceuticals and their potential to treat duchenne muscular dystrophy: separating the credible from the conjecture","volume":"8","author":"Woodman","year":"2016","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib139","doi-asserted-by":"crossref","first-page":"290","DOI":"10.7150\/thno.28671","article-title":"Direct in vivo application of induced pluripotent stem cells is feasible and can be safe","volume":"9","author":"Xiang","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174568_bib140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.7150\/thno.28671","article-title":"Direct in vivo application of induced pluripotent stem cells is feasible and can be safe","volume":"9","author":"Xiang","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib141","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.cell.2013.10.023","article-title":"A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species","volume":"155","author":"Xu","year":"2013","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ejphar.2021.174568_bib142","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0092-8674(00)81466-X","article-title":"Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation","volume":"93","author":"Yamaoka","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib143","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"5858","key":"10.1016\/j.ejphar.2021.174568_bib144","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"issue":"51","key":"10.1016\/j.ejphar.2021.174568_bib145","doi-asserted-by":"crossref","first-page":"33972","DOI":"10.1074\/jbc.273.51.33972","article-title":"Generation of superoxide anion by succinate-cytochromec reductase from bovine heart mitochondria","volume":"273","author":"Zhang","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ejphar.2021.174568_bib146","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay6812","article-title":"Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system","volume":"6","author":"Zhang","year":"2020","journal-title":"Science advances"},{"issue":"11","key":"10.1016\/j.ejphar.2021.174568_bib147","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/stem.201","article-title":"Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells","volume":"27","author":"Zhou","year":"2009","journal-title":"Stem cells"},{"issue":"7","key":"10.1016\/j.ejphar.2021.174568_bib148","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00439-019-02036-2","article-title":"Skipping of an exon with a nonsense mutation in the DMD gene is induced by the conversion of a splicing enhancer to a splicing silencer","volume":"138","author":"Zhu","year":"2019","journal-title":"Hum. Genet."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174568_bib149","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JND-160169","article-title":"FHL1B interacts with lamin A\/C and emerin at the nuclear lamina and is misregulated in emery-dreifuss muscular dystrophy","volume":"3","author":"Ziat","year":"2016","journal-title":"J. Neuromuscul. Dis."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100724X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100724X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:54:51Z","timestamp":1757976891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992100724X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":148,"alternative-id":["S001429992100724X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174568","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-editing, immunological and iPSCs based therapeutics for muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174568"}}